Japanese Society for Pharmacoepidemiology
The Japanese Society for Pharmacoepidemiology (JSPE) is an academic organization headquartered in Tokyo with the number of its permanent membership exceeding 500, and dedicated to the advancement of pharmacoepidemiology. Since it was founded at the society’s inaugural academic general meeting in December 1995, JSPE plays a crucial role in promoting high-quality research on the safety and efficacy of pharmaceuticals. It is committed to enhancing the risk management of medications, including minimizing risks, and fosters international collaborations and exchanges with stakeholders across the globe.
Through its activities, JSPE aims to contribute significantly to the development of pharmacoepidemiology, ensuring the safe and effective use of pharmaceuticals in healthcare.
President:
Hisashi Urushihara, Dr.PH, Professor
(Division of Drug Development & Regulatory Science Faculty of Pharmacy, Keio University )
Office:
5th Floor, Gakkai Center Bdg.
2-4-16 Yayoi, Bunkyo-ku, Tokyo, 113-0032 Japan
Phone/Fax:
+81-3-5802-8603,
e-mail:
History:
Founded in 1995, since then
the Conference has been held every year.
Current Member:
approximately 570, includes physician,
pharmacist, epidemiologist and statistician.
Publication:
Japanese Journal of Pharmacoepidemiology
(in Japanese), biannual publication, since 1996
16th Asian Conference on Pharmacoepidemiology and 29th Japanese Conference on Pharmacoepidemiology joint meeting
Date:
October 12-14, 2024
Chair:
Nobuhiro Ooba, PhD
Professor, Deparment of Pharmacoepidemiology
School of Pharmacy, Nihon University
Venue:
The University of Tokyo Yasuda Auditorium / Ito International Research Center
Address:
7-3-1 Hongo, Bunkyo-ku, Tokyo 113-8654, Japan
Secretary General:
Hiraku Kumamaru, MD, ScD
Associate Professor, Department of Healthcare Quality Assessment
The University of Tokyo Graduate School of Medicine
E-mail:
URL:
JSPE Updates
Sep,2023
The results of a survey of databases applicable to clinical epidemiology and pharmacoepidemiology in Japan
Nov,2022
The results of 2022 survey of databases applicable to clinical epidemiology and pharmacoepidemiology in Japan have been incorporated in “Database list & search site”
Aug,2021
Ethics in clinical researches, and history and current status of research ethics in Japan: Invited talk from Japan at the international symposium in Korea in June 2021
Nov.2020
Joint statement to consolidate the pharmacovigilance systems for securing safety of the COVID-19 vaccine products issued by Japanese Society for Pharmacoepidemiology, Japanese Epidemiological Association, Society for Clinical Epidemiology, and The Japanese Society for Vaccinology
Mar,2003
Provisional translation of the report of the working group on “Future Postmarketing Surveillance in Japan” is presented.